2.27
0.44%
+0.01
Check-Cap Ltd stock is currently priced at $2.27, with a 24-hour trading volume of 20,001.
It has seen a +0.44% increased in the last 24 hours and a +22.02% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $2.24 pivot point. If it approaches the $2.36 resistance level, significant changes may occur.
Check-Cap Ltd Stock (CHEK) Financials Data
Check-Cap Ltd (CHEK) Net Income 2024
CHEK net income (TTM) was -$17.62 million for the quarter ending September 30, 2023, a +15.57% increase year-over-year.
Check-Cap Ltd (CHEK) Cash Flow 2024
CHEK recorded a free cash flow (TTM) of -$17.74 million for the quarter ending September 30, 2023, a +9.52% increase year-over-year.
Check-Cap Ltd (CHEK) Earnings per Share 2024
CHEK earnings per share (TTM) was -$3.015 for the quarter ending September 30, 2023, a +23.86% growth year-over-year.
Check-Cap Ltd Stock (CHEK) Latest News
About Check-Cap Ltd
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
Cap:
|
Volume (24h):